Generali Investments CEE investicni spolecnost a.s. Buys New Holdings in Cardinal Health, Inc. (NYSE:CAH)

Generali Investments CEE investicni spolecnost a.s. purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 6,000 shares of the company’s stock, valued at approximately $710,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CAH. State Street Corp raised its stake in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after acquiring an additional 627,253 shares during the period. Geode Capital Management LLC lifted its stake in shares of Cardinal Health by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after buying an additional 42,082 shares during the last quarter. Pacer Advisors Inc. grew its stake in Cardinal Health by 4.7% in the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after buying an additional 191,568 shares during the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Cardinal Health by 3.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,519,011 shares of the company’s stock valued at $179,653,000 after acquiring an additional 44,386 shares during the period. Finally, Two Sigma Advisers LP boosted its holdings in shares of Cardinal Health by 47.9% during the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after acquiring an additional 346,362 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

NYSE CAH opened at $126.40 on Friday. The business has a fifty day moving average price of $125.58 and a two-hundred day moving average price of $118.82. The stock has a market capitalization of $30.53 billion, a PE ratio of 23.58, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $132.84.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is 37.69%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on CAH shares. Argus set a $148.00 target price on Cardinal Health in a research note on Tuesday, February 4th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Morgan Stanley upped their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, January 31st. Wells Fargo & Company raised their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.